NGM Biopharmaceuticals, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| NGM Biopharmaceuticals, Inc. | NGM - NASDAQ |
$14.00-$16.00 | $16.00 | $15.00 | 6.67 million | 4/4/2019 |
| Goldman Sachs, Citigroup, Cowen | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2018-09-28 Terms Added 2019-03-25 | ||||||
NGM Biopharmaceuticals, Inc. Quote & Chart - Click for current quote - NGM
IPO Boutique aggregates information on public companies and private companies, such as "NGM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About NGM Biopharmaceuticals, Inc. (adapted from NGM Biopharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing novel therapeutics based on our scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic and ophthalmic diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company developing novel therapeutics based on our scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic and ophthalmic diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "NGM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.